News

March 30, 2016March 30, 2016

$3.6M Grant Awarded to Pediatric Asthma Intervention Researcher

Asthma, News

The University of Rochester Medical Center (URMC) recently reported that Jill Halterman, M.D., was awarded a $3.6 million grant from the National Institutes of Health (NIH) to carry out research ... Read more

March 30, 2016April 4, 2016

Cytori Updates Phase 3 Scleroderma Trial After Enrolling, Treating 40th Patient

News, Scleroderma

Cytori Therapeutics recently announced that its FDA-approved Phase 3 STAR clinical trial on ECCS-50 has enrolled and treated its 40th patient, reaching 50 percent of its target enrollment. Additionally, an independent ... Read more

March 29, 2016March 30, 2016

Sleep Apnea Group Awarded $2.5M for COPD/Apnea Overlap Syndrome Study

COPD, News

The American Sleep Apnea Association (ASAA) announced that the Patient-Centered Outcomes Research Institute (PCORI)’s Board of Governors has approved $2.5 million in funding for a three-year demonstration project titled “Monitoring and ... Read more

March 29, 2016May 13, 2016

Cystic Fibrosis Patients May Have Better Treatment Options with Personalized Medicine

Cystic Fibrosis, News

Personalized medicine may offer better treatment options for highly variable diseases such as cystic fibrosis (CF), where treatments are based on individual factors right down to the molecular level. This is particularly ... Read more

March 29, 2016May 13, 2016

Digital Aid to Manage COPD and Asthma Being Made Available to RESPIMAT Inhaler Users

Asthma, COPD, News

Propeller Health and Boehringer Ingelheim Pharmaceuticals recently announced a commercial collaboration, based on joint use of the companies’ health tools and services, in an effort to help people better manage long-term lung conditions like asthma and ... Read more

March 28, 2016March 28, 2016

FDA Approves Teva’s Asthma Drug Cinqair as Add-on Treatment

Asthma, News

Teva Pharmaceutical Industries recently announced the approval of Cinqair (reslizumab) injection by the U.S. Food and Drug Administration (FDA) as an add-on maintenance treatment for patients with severe asthma, age 18 and ... Read more

March 28, 2016March 28, 2016

Boehringer Ingelheim Enrolls 1st Patient in ‘Real World’ Study of Pradaxa for Deep Vein Thrombosis and PE

News, Pulmonary embolism

Boehringer Ingelheim pharmaceutical company recently announced the launch and enrollment of the first patient in its RE-COVERY DVT/PE global observational study, which will eventually include 14,000 patients globally and collect data on ... Read more

March 28, 2016April 4, 2016

Drug Company Collaboration for IPF Therapy Leads to Positive Results; Phase 1 Trial to Launch in 2017

Idiopathic Pulmonary Fibrosis, News

Synairgen recently announced positive results from its collaboration with Pharmaxis in their goal to develop a lysyl oxidase type 2 enzyme (LOXL2) inhibitor as an innovative treatment for the life-threatening lung disease ... Read more

March 24, 2016March 24, 2016

Researchers Build Promising CF Diagnostic System Using Microsoft’s Xbox Kinect Sensors

Cystic Fibrosis, News

In a new study, researchers describe the development of a low-cost and effective chest wall motion assessment system, essential for the rapid and accurate diagnosis of respiratory diseases, that uses ... Read more

March 24, 2016March 24, 2016

Actelion’s PAH Therapy, Uptravi (selexipag), Approved for Use in Australia and New Zealand

News, Pulmonary Hypertension

Actelion, Ltd., recently announced the approval of Uptravi (selexipag) by the Therapeutic Goods Administration (TGA) of Australia and the New Zealand Medicines and Medical Devices Safety Authority (Medsafe) for the treatment ... Read more